A detailed history of Jpmorgan Chase & CO transactions in Perkinelmer Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 288,268 shares of PKI stock, worth $34.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
288,268
Previous 318,825 9.58%
Holding current value
$34.9 Million
Previous $38.6 Million 9.58%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
N/A
-30,557 Reduced 9.58%
288,268 $34.9 Million
Q1 2024

May 10, 2024

BUY
N/A
89,384 Added 38.96%
318,825 $38.6 Million
Q4 2023

Feb 12, 2024

SELL
N/A
-34,088 Reduced 12.94%
229,441 $27.8 Million
Q3 2023

Nov 14, 2023

SELL
$115.88 - $122.81 $1.43 Million - $1.52 Million
-12,376 Reduced 4.49%
263,529 $31.9 Million
Q2 2023

Aug 11, 2023

BUY
$0.0 - $137.11 $0 - $3.91 Million
28,539 Added 11.54%
275,905 $0
Q1 2023

May 18, 2023

BUY
$120.16 - $144.38 $7.14 Million - $8.58 Million
59,455 Added 31.64%
247,366 $33 Million
Q1 2023

May 11, 2023

BUY
$120.16 - $144.38 $4.16 Million - $5 Million
34,650 Added 22.61%
187,911 $25 Million
Q4 2022

Feb 13, 2023

BUY
$119.0 - $147.98 $634,746 - $789,325
5,334 Added 3.61%
153,261 $21.5 Million
Q3 2022

Nov 14, 2022

SELL
$118.07 - $160.96 $1.38 Million - $1.88 Million
-11,684 Reduced 7.32%
147,927 $17.8 Million
Q2 2022

Aug 11, 2022

SELL
$134.91 - $172.49 $18.5 Million - $23.7 Million
-137,475 Reduced 46.27%
159,611 $22.7 Million
Q1 2022

May 11, 2022

SELL
$162.31 - $192.2 $87.9 Million - $104 Million
-541,803 Reduced 64.59%
297,086 $51.8 Million
Q4 2021

Feb 10, 2022

BUY
$166.66 - $201.06 $31.8 Million - $38.3 Million
190,630 Added 29.41%
838,889 $169 Million
Q3 2021

Nov 12, 2021

BUY
$151.98 - $190.5 $98.5 Million - $123 Million
648,259 New
648,259 $112 Million

Others Institutions Holding PKI

About PERKINELMER INC


  • Ticker PKI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 126,224,000
  • Market Cap $15.3B
  • Description
  • PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detectio...
More about PKI
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.